iShares US Pharmaceuticals ETF (IHE)
64.52
+0.53
(+0.83%)
USD |
NYSEARCA |
May 29, 15:50
Key Stats
Customize
| Net Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| 0.39% | -0.03% | 547.27M | 114927.6 |
| Weighted Average Dividend Yield | Turnover Ratio (Generic) | 1 Year Fund Level Flows | Max Drawdown (Since Inception) |
| 2.07% | 42.00% | -105.68M | Upgrade |
Basic Info
| Investment Strategy | |
| The Fund seeks to track the investment results of the Dow Jones US Select Pharmaceuticals Index composed of US equities in the pharmaceuticals sector. The Fund invests at least 90% of its assets in securities of the Underlying Index and in depositary receipts representing securities of the Underlying Index. |
| General | |
| Security Type | Exchange-Traded Fund |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Health/Biotechnology Funds |
| Fund Owner Firm Name | BlackRock |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of May 29, 2025.
Asset Allocation
As of April 30, 2025.
| Type | % Net |
|---|---|
| Cash | 0.06% |
| Stock | 99.88% |
| Bond | 0.06% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | 0.00% |
Basic Info
| Investment Strategy | |
| The Fund seeks to track the investment results of the Dow Jones US Select Pharmaceuticals Index composed of US equities in the pharmaceuticals sector. The Fund invests at least 90% of its assets in securities of the Underlying Index and in depositary receipts representing securities of the Underlying Index. |
| General | |
| Security Type | Exchange-Traded Fund |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Health/Biotechnology Funds |
| Fund Owner Firm Name | BlackRock |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |